LOQOA Trademark

Trademark Overview

On Wednesday, September 2, 2020, a trademark application was filed for LOQOA with the United States Patent and Trademark Office. The USPTO has given the LOQOA trademark a serial number of 79295627. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, February 18, 2024. This trademark is owned by TAISHO PHARMACEUTICAL CO., LTD.. The LOQOA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-inflammatory preparations and analgesics
loqoa

General Information

Serial Number79295627
Word MarkLOQOA
Filing DateWednesday, September 2, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, February 18, 2024
Registration Number6399036
Registration DateTuesday, June 29, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-inflammatory preparations and analgesics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, February 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTAISHO PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameTAISHO PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameTAISHO PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Thursday, October 8, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, October 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 20, 2020APPLICATION FILING RECEIPT MAILED
Friday, January 8, 2021ASSIGNED TO EXAMINER
Friday, March 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 13, 2021NON-FINAL ACTION WRITTEN
Thursday, January 14, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 1, 2021REFUSAL PROCESSED BY MPU
Monday, February 1, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, February 28, 2021REFUSAL PROCESSED BY IB
Friday, March 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, April 12, 2021NOTIFICATION PROCESSED BY IB
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 29, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 29, 2021REGISTERED-PRINCIPAL REGISTER
Sunday, December 12, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 25, 2021GENERIC MADRID TRANSACTION CREATED
Monday, October 25, 2021GENERIC MADRID TRANSACTION SENT TO IB
Monday, September 9, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, September 9, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Related Keywords

loqoa preparations analgesics inflammatory namely pharmaceutical anti